ClinicalTrials.gg
CompletedNCT06525805Updated Nov 8, 2024

Readers' Attention of Shorter Versus Longer Abstracts of Systematic Reviews

An interventional study of Long Abstract and Short Abstract in Researchers Attention, sponsored by University of Oldenburg. Completed at 1 site in Germany. Per ClinicalTrials.gov, last updated 2024-11-08.

Sponsored by University of Oldenburg · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,941
Allocation
Randomized
Sex
All
01

Study summary

The present randomized controlled trial (RCT) was designed to investigate the perceptions of researchers on systematic review (SR) abstracts. The primary objective will be to compare readers' attention of shorter versus longer abstracts. The secondary objective will be to assess the perception of an abstract based on four indicators of a well-written abstract: (a) Informativeness, (b) Accuracy, (c) Attractiveness, and (d) Conciseness.

The study will involve researchers from all over the world who recently published an SR, regardless of their research field. To identify eligible authors, a search of MEDLINE (via PubMed) was conducted on May 5, 2024, for systematic reviews published between January 1, 2024, and March 26, 2024. A total of at least 6200 SRs will be selected from PubMed and assessed for eligibility. The corresponding author information will be extracted from all included SRs and randomized in a 1:1 ratio.

Read the detailed description

This study will attempt to emulate the reading process observed in PubMed. When searching PubMed, researchers are initially presented with an overview of the references identified. After clicking on the title, the corresponding abstract appears. For full-text access, researchers must actively follow a separate link to the journal page.

In this RCT, participants will be randomly assigned in a 1:1 ratio to two groups (those receiving a long abstract vs. those receiving a short abstract). Both groups receive the same cover letter by e-mail explaining the purpose of the study, the use of the data, measures to ensure anonymity of participation, and a link for participation.

The link will direct participants to SoSci Survey, an online survey tool. Those in the group receiving the long abstract will see an abstract with a length of 771 words (PMID: 37955353). Those in the group receiving the short abstract will see an abstract with a length of 277 words (PMID: 37942649). Both abstracts are structured and pertain to the same review entitled "Percutaneous nephrolithotomy vs. retrograde intrarenal surgery for renal stones". This review was published once in the Cochrane Database of Systematic Reviews and once in the journal BJU International.

The design of the abstract presented is similar to that of PubMed, but no title or authors will be indicated. After reading the abstract, participants must actively click the "Continue" button to proceed with the survey.

02

Conditions studied

  • Researchers Attention
03

In context

Lead sponsor

University of Oldenburg is the lead sponsor of 6 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

The corresponding authors of systematic reviews that were indexed in PubMed between January 1, 2024, and March 26, 2024, and for which an English abstract is available will be included. These include authors of all types of SR, with the majority likely representing SRs on effectiveness. Authors of other types of evidence syntheses (e.g. scoping reviews, methodological papers), editorials, protocols, corrections, retractions, erratums, or summaries of SRs will be excluded.

For identifying the systematic reviews from which the corresponding authors will be contacted we will use the following eligibility criteria.

Inclusion criteria

Inclusion Criteria:

  • Systematic reviews of all types

Exclusion criteria

Exclusion Criteria:

  • No English abstract
  • Other types of evidence syntheses (e.g. scoping reviews, methodological papers)
  • Protocols
  • Editorials
  • Others: e.g. Corrections, retractions, erratums, or summaries of SRs
  • No email address available
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
1,941 participants (actual)

Study arms

  • Experimental
    Long Abstract

    Abstract length: 771 words

    Other: Long Abstract

  • Active comparator
    Short Abstract

    Abstract length: 277 words

    Other: Short Abstract

Interventions

  • OtherLong Abstract

    The intervention and control group will be provided with a structured abstract of the review by Soderberg et al., entitled "Percutaneous nephrolithotomy vs. retrograde intrarenal surgery for renal stones". This review was published once in the Cochrane Database of Systematic Reviews and once in the journal BJU International. The length of the abstract differs significantly depending on the journal. The participants assigned to this study arm will be presented with the longer version published in the Cochrane Database, comprising 771 words (PMID: 37955353).

  • OtherShort Abstract

    The participants assigned to this study arm will be presented with the shorter version published in BJU International, comprising 277 words (PMID: 37942649).

06

What researchers measure

Primary outcomes

  1. Trial participation

    The primary outcome of this RCT will be the trial participation, which is defined as the proportion of participants who read the abstract and then clicked on the "Continue" button. This will be quantified by dividing the number of participants who read the abstract and proceeded to complete the survey by the total number of individuals who clicked on the link in the email. Information will be electronically captured in SoSci survey.

    Time frame: Immediately after reading the abstract

Secondary outcomes

  1. Indicators of a well-written abstract

    The secondary outcomes will be four indicators of a well-written abstract, as follows: 1. Informativeness 2. Accuracy 3. Attractiveness 4. Conciseness. The extent to which participants perceive these criteria to be fulfilled will be quantified on a 4-point Likert scale, e.g. very little informative, little informative, informative, very informative. For data analysis, the data will be dichotomized. For instance, the statements "very little informative" and "little informative" will be summarized in the category "non-informative," while the statements "informative" and "very informative" will be summarized in the category "informative."

    Time frame: Immediately after reading the abstract

Other outcomes

  1. Time needed to read the abstract

    The time needed to read the abstract will be quantified. The time interval is defined as the period between the participant clicking on the link in the email and clicking on the "Continue" button to proceed to the survey. This time will be automatically recorded by SoSci Survey.

    Time frame: Immediately after reading the abstract

07

Study locations

1 site
  • Carl von Ossietzky Universität Oldenburg
    Oldenburg, Germany
08

References and documents

Publications

  • Bahadoran Z, Mirmiran P, Kashfi K, Ghasemi A. The Principles of Biomedical Scientific Writing: Abstract and Keywords. Int J Endocrinol Metab. 2020 Jan 28;18(1):e100159. doi: 10.5812/ijem.100159. eCollection 2020 Jan. PubMed 32308700 ↗
  • Munn Z, Stern C, Aromataris E, Lockwood C, Jordan Z. What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences. BMC Med Res Methodol. 2018 Jan 10;18(1):5. doi: 10.1186/s12874-017-0468-4. PubMed 29316881 ↗
  • Soderberg L, Ergun O, Ding M, Parker R, Borofsky MS, Pais V, Dahm P. Percutaneous nephrolithotomy versus retrograde intrarenal surgery for treatment of renal stones in adults. Cochrane Database Syst Rev. 2023 Nov 13;11(11):CD013445. doi: 10.1002/14651858.CD013445.pub2. PubMed 37955353 ↗
  • Soderberg L, Ergun O, Ding M, Parker R, Borofsky M, Pais V, Dahm P. Percutaneous nephrolithotomy vs retrograde intrarenal surgery for renal stones: a Cochrane Review. BJU Int. 2024 Feb;133(2):132-140. doi: 10.1111/bju.16220. Epub 2023 Nov 29. PubMed 37942649 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2024 to primary completion in Sep 2024, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 18, 2024
First posted
Jul 29, 2024
StartActual
Aug 1, 2024
Primary completionActual
Sep 30, 2024
CompletionActual
Sep 30, 2024
Last update
Nov 8, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 8, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06525805
Lead sponsor
University of Oldenburg
Responsible party
Jasmin Helbach (Principal Investigator, University of Oldenburg) — Principal investigator
First posted
Jul 29, 2024
Start date
Aug 1, 2024
Primary completion
Sep 30, 2024
Completion
Sep 30, 2024
Last update
Nov 8, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion